Claim OwnershipDishing The Science with Dr. Sue
Subscribed: 1Played: 7
Subscribe
© 2024 Dishing The Science with Dr. Sue
Description
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine.
Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixed in too! With over 20 years (and counting) of experience as a physician, I always report, share, and interpret the information with the person living with obesity or diabetes as the focus. With nearly 3 million hits on my blog to date, I am sure you will find something important to you/your patients. I'm excited to share this journey with you!
32 Episodes
Reverse
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped?Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is no...
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know?Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult y...
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to the...
As many as 1 BILLION adults worldwide are estimated to have obstructive sleep apnea (OSA), and 70% of people with OSA have obesity. How much does sleep apnea improve with weight loss, and does it matter how the weight is lost (with lifestyle, weight management medication, or bariatric surgery)?Learn more: https://drsue.ca/2024/04/how-much-does-sleep-apnea-improve-with-weight-loss-and-does-it-matter-how-the-weight-is-lost/Any medical discussion on this podcast is intended to be of a general na...
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us? Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical ...
Older data have shown that obesity medications are prescribed far less frequently than medications for other chronic medical conditions. Much has changed in recent years in the weight management world. How has this impacted prescribing of weight management medication?Learn more: https://drsue.ca/2024/04/how-many-people-with-obesity-actually-receive-prescriptions-for-weight-management-medication/Any medical discussion on this podcast is intended to be of a general nature only, and is intended ...
Articles have gone viral this week regarding women getting pregnant on diabetes/weight management GLP1-based medications, particularly semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). What do you need to know?Learn more: https://drsue.ca/2024/04/mounjaro-ozempic-babies-in-the-media-what-you-need-to-know/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for ...
Oprah Winfrey recently hosted a special called 'Shame, Blame, and the Weight Loss Revolution'. What will the Oprah Effect be on obesity medicine? Learn more: https://drsue.ca/2024/03/what-will-the-oprah-effect-be-on-obesity-medicine/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical pr...
Resmetirom is the first treatment ever approved for fatty liver disease. Could GLP1 based obesity/diabetes medications have similar benefits? Learn more: https://drsue.ca/2024/03/first-medication-ever-approved-to-treat-fatty-liver-disease-how-will-glp1-based-obesity-diabetes-medications-stack-up/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, no...
With the emergence of medications that are very powerful for weight loss, some people may lose too much weight. This can include excessive loss of muscle mass, a condition called sarcopenia. How should we look for and diagnose sarcopenia? Learn more: https://drsue.ca/2024/03/how-can-we-diagnose-sarcopenia-excessive-loss-of-muscle-in-people-successfully-losing-weight/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience...
The DiRECT 5 year trial of diabetes remission with lifestyle was just published. Does this study suggest that we should 'DiRECT' our patients towards lifestyle treatment alone? Learn more: https://drsue.ca/2024/03/diabetes-remission-should-we-direct-patients-towards-lifestyle-change-alone/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor...
Guidelines currently recommend lifestyle change as a strategy to achieve diabetes remission. But is diabetes remission with lifestyle change alone a realistic long term goal?Learn more: https://drsue.ca/2024/02/is-diabetes-remission-with-lifestyle-change-a-realistic-long-term-goal/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their heal...
Will glucagon with GLP-1 be a new combination weight management treatment? How could these 2 hormones work together to facilitate weight loss?Learn more: https://drsue.ca/2024/02/will-glucagon-with-glp1-be-a-new-combination-weight-management-treatment/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If yo...
There are many important strategies to protect the kidneys of people with type 2 diabetes. Could a longer time at a target weight loss be one of them? Learn more: https://drsue.ca/2024/02/could-spending-more-time-at-a-target-weight-protect-against-kidney-failure-in-people-with-type-2-diabetes/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor t...
Rare post marketing case reports of suicidality have emerged amongst people taking GLP1 receptor agonists for diabetes or obesity. What new data do we have on this, and where are global regulatory agencies at in their investigations? Learn more: https://drsue.ca/2024/01/update-are-glp1-receptor-agonist-medications-for-weight-management-and-diabetes-associated-with-suicide-risk/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian aud...
What are the risks associated with the RSV virus, and should you be vaccinated?Learn more: https://drsue.ca/2024/01/should-you-get-the-rsv-vaccine/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Posti...
Why do so many people stop weight management medication - and why does it matter? Learn more: https://drsue.ca/2024/01/why-do-so-many-people-stop-their-weight-management-medication/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice sp...
We know that elevated weight is a key risk factor for developing type 2 diabetes. Does carrying elevated weight increase the risk of developing autoimmune type 1 diabetes as well? Learn more: https://drsue.ca/2024/01/does-obesity-increase-the-risk-of-developing-autoimmune-type-1-diabetes/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to the...
Miss any key advancements and challenges in the field of weight management in 2023? Join me for the highlights here!Learn more: https://drsue.ca/2023/12/dr-sues-weight-management-highlights-2023/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician ...
Could Alexa AI help people titrate insulin (for diabetes) or GLP1 receptor agonists (for diabetes or weight management)? Learn more: https://drsue.ca/2023/12/could-ai-help-to-optimize-insulin-or-glp1-receptor-agonist-therapy/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you shou...
Comments
Download from Google Play
Download from App Store
United States